Key facts
- This page summarizes Bruce Colwill's Form 4 filing for InMed Pharmaceuticals Inc. (INM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 Jan 2022, 13:02.
Bruce Colwill - 24 Jan 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)
- Reporting relationship
- CFO
- Issuer ticker
- INM
- Reported as of
- 24 Jan 2022
- Net transaction value
- +$5,438
- SEC form
- 4
- Accepted by SEC
- 24 Jan 2022, 13:02:34 UTC
- Prior SEC filing
- 19 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Bruce Colwill
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Bruce Colwill filed Form 4 for InMed Pharmaceuticals Inc. (INM) on 24 Jan 2022.
Change
- Previous filing in this sequence was filed on 19 Oct 2021.
- Current net transaction value: +$5,438.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INM
transaction
Common Stock
Purchase
- Transaction value
- $5,438
- Shares
- +5,000
- Change %
- +77%
- Price
- $1.09
- Shares after
- 11,515
- Date
- 24 Jan 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.